India’s IPO pipeline expands as Sebi clears papers for Carlsberg India, Matangi Rubber, Ujin Pharma and TMC Transformer. The approvals come...

Ashok Leyland's June-quarter has an unusual contradiction. The company sold 48,763 commercial vehicles, its highest-ever first-quarter volu...

September 2025 marked a significant increase in Draft Red Herring Prospectuses submitted to Sebi with 55 submissions. Companies with a Marc...

Indian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...

Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...

Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...

India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...

The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

CoinSwitch achieved profitability based on Adjusted EBITDA for FY26, with revenue growth of 150%. The company's revenue reached Rs 324.19 c...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...

An increase in total orders fulfilled supported a more than 20% sequential jump in Shein's second-quarter net revenue, although the Iran co...

Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...

HRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...

Indian equities suffered a sharp selloff, with Sensex plunging 1,248 points and Nifty falling 1.6% as US Treasury yields hit 19-year highs,...

JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...